Volume 12 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
Huang Yabing, Guo Hui, Guan Yang, et al. Progress on electron microscopy diagnosis on Banff classification for renal allograft pathology[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 391-396. doi: 10.3969/j.issn.1674-7445.2021.04.004
Citation: Huang Yabing, Guo Hui, Guan Yang, et al. Progress on electron microscopy diagnosis on Banff classification for renal allograft pathology[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 391-396. doi: 10.3969/j.issn.1674-7445.2021.04.004

Progress on electron microscopy diagnosis on Banff classification for renal allograft pathology

doi: 10.3969/j.issn.1674-7445.2021.04.004
More Information
  • Corresponding author: Guan Yang, Email: guanyang@foxmail.com; Zhong Weixiong, Email: wzhong3@wisc.edu
  • Received Date: 2021-05-07
    Available Online: 2021-07-13
  • Publish Date: 2021-07-15
  • With the development of organ transplantation in clinical practice, allograft pathology has been constantly developing and advancing. The convening of Banff conference on allograft pathology and the establishment of Banff classification on allograft pathology (Banff classification) are pivotal milestones in the development of international allograft pathology. Since then, Banff classification on pathological diagnosis of various transplant organs have been continually updated and improved. Ultrastructural pathological observation by electron microscope plays an irreplaceable role in the early diagnosis of antibody-mediated rejection, recurrent disease and de novo disease of renal allograft. Early detection and rational treatment help to maintain the long-term survival of renal allograft and reduce the failure of renal allograft. In this article, the basic definition of electron microscope and the ultrastructural pathological diagnosis, the research history and main progress on electron microscope diagnosis on Banff classification for renal allograft pathology were introduced, and typical pathological changes, specific terminology and diagnostic criteria of electron microscope diagnosis on renal allograft biopsy were summarized, aiming to provide reference for clinical and basic research of organ transplantation.

     

  • loading
  • [1]
    郭晖, 陈刚. Banff移植病理学诊断标准的起源、发展及对器官移植的推动作用[J]. 器官移植, 2021, 12(1): 15-22. DOI: 10.3969/j.issn.1674-7445.2021.01.003.

    GUO H, CHEN G. The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation[J]. Organ Transplant, 2021, 12(1): 15-22. DOI: 10.3969/j.issn.1674-7445.2021.01.003.
    [2]
    郭晖. 移植肾抗体介导的排斥反应的病理学[J]. 器官移植, 2021, 12(3): 262-271. DOI: 10.3969/j.issn.1674-7445. 2021.03.003.

    GUO H. Pathology of antibody-mediated rejection in renal allograft[J]. Organ Transplant, 2021, 12(3): 262-271. DOI: 10.3969/j.issn.1674-7445.2021.03.003.
    [3]
    YOKOYAMA H, OKADA S, YAMADA Y, et al. Low-vacuum scanning electron microscopy may allow early diagnosis of human renal transplant antibody-mediated rejection[J]. Biomed Res, 2020, 41(2): 81-90. DOI: 10. 2220/biomedres.41.81.
    [4]
    ONISHI H, OGUCHI H, SHINODA K, et al. Pathological analysis of early transplant glomerulopathy in renal allografts using low-vacuum scanning electron microscopy[J]. Nephron, 2020, 144 (Suppl 1): 71-78. DOI: 10.1159/000512136.
    [5]
    MOROZUMI K, TAKEDA A, OTSUKA Y, et al. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation[J]. Nephrology (Carlton), 2016, 21 (Suppl 1): 4-8. DOI: 10.1111/nep.12777.
    [6]
    武忠弼. 超微病理诊断学[M]. 上海: 上海科学技术出版社, 2003.
    [7]
    史景泉, 陈意生, 卞修武. 超微病理学[M]. 北京: 化学工业出版社, 2005.
    [8]
    HAAS M. Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts[J]. Curr Opin Nephrol Hypertens, 2018, 27(3): 137-143. DOI: 10.1097/MNH.0000000000000398.
    [9]
    CHAPMAN JR, WAVAMUNNO M, O'CONNELL PJ, et al. Unravelling the connections between donor specific antibodies and renal allograft pathology[J]. Clin Transpl, 2013: 361-365. http://europepmc.org/abstract/med/25095530
    [10]
    HAAS M. Pathology of C4d-negative antibody-mediated rejection in renal allografts[J]. Curr Opin Organ Transplant, 2013, 18(3): 319-326. DOI: 10.1097/MOT.0b013e32835d4daf.
    [11]
    PAPADIMITRIOU JC, DRACHENBERG CB, RAMOS E, et al. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies[J]. Transplantation, 2013, 95(1): 128-136. DOI: 10.1097/TP.0b013e3182777f28.
    [12]
    SNIJDERS MLH, VAROL H, VAN DER ZWAN M, et al. Molecular analysis of renal allograft biopsies: where do we stand and where are we going?[J]. Transplantation, 2020, 104(12): 2478-2486. DOI: 10.1097/TP.0000000000003220.
    [13]
    KIM MY, BRENNAN DC. Therapies for chronic allograft rejection[J]. Front Pharmacol, 2021, 12: 651222. DOI: 10.3389/fphar.2021.651222.
    [14]
    SOLAR-CAFAGGI D, MARINO L, URIBE-URIBE N, et al. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: a comparison of renal graft loss prediction capability[J]. Transpl Immunol, 2018, 51: 40-44. DOI: 10.1016/j.trim.2018.08.008.
    [15]
    HAAS M. The revised (2013) Banff classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations[J]. Am J Transplant, 2016, 16(5): 1352-1357. DOI: 10.1111/ajt.13661.
    [16]
    MONGA G, MAZZUCCO G, NOVARA R, et al. Intertubular capillary changes in kidney allografts: an ultrastructural study in patients with transplant glomerulopathy[J]. Ultrastruct Pathol, 1990, 14(3): 201-209. DOI: 10.3109/01913129009076124.
    [17]
    MONGA G, MAZZUCCO G, MESSINA M, et al. Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens[J]. Mod Pathol, 1992, 5(2): 125-130.
    [18]
    FILIPPONE EJ, MCCUE PA, FARBER JL. Transplant glomerulopathy[J]. Mod Pathol, 2018, 31(2): 235-252. DOI: 10.1038/modpathol.2017.123.
    [19]
    VAZQUEZ MARTUL E. The pathology of renal transplants[J]. Rev Esp Patol, 2018, 51(2): 110-123. DOI: 10.1016/j.patol.2017.10.001.
    [20]
    LOUPY A, HAAS M, SOLEZ K, et al. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology[J]. Am J Transplant, 2017, 17(1): 28-41. DOI: 10.1111/ajt.14107.
    [21]
    LOUPY A, HAAS M, ROUFOSSE C, et al. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection[J]. Am J Transplant, 2020, 20(9): 2318-2331. DOI: 10.1111/ajt.15898.
    [22]
    HAAS M, LOUPY A, LEFAUCHEUR C, et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials[J]. Am J Transplant, 2018, 18(2): 293-307. DOI: 10.1111/ajt.14625.
    [23]
    DE SERRES SA, NOËL R, CÔTÉ I, et al. 2013 Banff criteria for chronic active antibody-mediated rejection: assessment in a real-life setting[J]. Am J Transplant, 2016, 16(5): 1516-1525. DOI: 10.1111/ajt.13624.
    [24]
    SENEV A, COEMANS M, LERUT E, et al. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome[J]. Am J Transplant, 2019, 19(3): 763-780. DOI: 10.1111/ajt.15074.
    [25]
    SABLIK KA, CLAHSEN-VAN GRONINGEN MC, LOOMAN CWN, et al. Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study[J]. Transpl Int, 2018, 31(8): 900-908. DOI: 10.1111/tri.13154.
    [26]
    PARAJULI S, REDFIELD RR, GARG N, et al. Clinical significance of microvascular inflammation in the absence of anti-HLA DSA in kidney transplantation[J]. Transplantation, 2019, 103(7): 1468-1476. DOI: 10.1097/TP.0000000000002487.
    [27]
    WANG J, LI X, WU X, et al. Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation[J]. Appl Microbiol Biotechnol, 2021, 105(6): 2473-2484. DOI: 10.1007/s00253-020-11069-x.
    [28]
    CLOTET-FREIXAS S, MCEVOY CM, BATRUCH I, et al. Extracellular matrix injury of kidney allografts in antibody-mediated rejection: a proteomics study[J]. J Am Soc Nephrol, 2020, 31(11): 2705-2724. DOI: 10.1681/ASN.2020030286.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Article Metrics

    Article views (794) PDF downloads(147) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return